Cox J L, Boineau J P, Schuessler R B, Jaquiss R D, Lappas D G
Department of Surgery, Washington University School of Medicine, Barnes Hospital, St. Louis, Mo, USA.
J Thorac Cardiovasc Surg. 1995 Aug;110(2):473-84. doi: 10.1016/S0022-5223(95)70244-X.
The original maze procedure that was described for the treatment of patients with atrial fibrillation was followed by an unacceptable incidence of two problems: (1) the frequent inability to generate an appropriate sinus tachycardia in response to maximal exercise and (2) occasional left atrial dysfunction. In an effort to overcome these problems, we modified the original technique (maze I) twice. The results of these modifications culminated in the maze III procedure, which is associated with a higher incidence of postoperative sinus rhythm, improved long-term sinus node function, fewer pacemaker requirements, less arrhythmia recurrence, and improved long-term atrial transport function. In addition, the maze III procedure is technically less demanding than either the maze I or maze II procedure. Therefore, the maze III procedure is now the technique of choice for the management of medically refractory atrial fibrillation.
最初描述的用于治疗心房颤动患者的迷宫手术出现了两个问题，其发生率令人难以接受：（1）在最大运动量时频繁无法产生适当的窦性心动过速；（2）偶尔出现左心房功能障碍。为了克服这些问题，我们对原始技术（迷宫I）进行了两次修改。这些修改的结果最终形成了迷宫III手术，其术后窦性心律发生率更高、长期窦房结功能改善、起搏器需求减少、心律失常复发较少且长期心房运输功能改善。此外，迷宫III手术在技术上的要求低于迷宫I或迷宫II手术。因此，迷宫III手术现在是治疗药物难治性心房颤动的首选技术。
